Sientra up on approval to market breast implants in Canada
24/03/2022 16:23
** Shares of medical aesthetics co SIEN.O rise 3.6% to
$2.55
** Co receives approval from Health Canada to market its
silicone gel breast implants in the country urn:newsml:reuters.com:*:nGNX23CtcJ
** Sientra will market the product in Canada through its
local partner Kai Aesthetic
** All seven brokerages covering the stock rate it "buy" or
higher; their median PT is $8.50
** Including session's moves, stock has lost ~29.6% YTD
(Reporting by Mrinalika Roy in Bengaluru)
((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))
Recent news on Project Sage Oldco
See all newsBrief: Sientra Says Bankruptcy Court Entered An Order Approving Dip Credit Agreement On An Interim Basis On Feb 14
Brief: Sientra To Pursue Strategic Sale Of Its Business Through Voluntary Chapter 11 Process
U.S. STOCKS ON THE MOVE-premarket
Brief: Sientra Files For Voluntary Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Sientra Says Co Entered Into Amendment No. 2 To Temporary Waiver And Exchange Agreement And Temporary Amendment To Facility Agreement